Product Information
PHENTERMINE 30 MG CAPSULE is a generic product labeled by TAGI Pharma Inc., priced at $0.1044 per EA under NDC 51224020270. Its NADAC has been published 560 times since Nov 28, 2013.
Strength
30 mg/1
Manufacturer
TAGI Pharma Inc.NDC
51224020270
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
7/17/2024
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202248On Market Since
2/17/2012
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 30 MG CAPSULE has been published 560 times since Nov 28, 2013, and over the history we have for it it has declined 52.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1044 per EA |
|---|---|
| All-time high | $0.2543 (Feb 12, 2014) |
| All-time low | $0.1044 (Jul 17, 2024) |
| Median price | $0.1662 |
| Average price | $0.1695 |
| Largest weekly change | +58.1% (Mar 20, 2024) |
| Weeks tracked | 560 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENTERMINE 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 30 MG CAPSULE, manufactured by TAGI Pharma Inc., is $0.1044 per EA (NDC 51224020270), effective Aug 14, 2024.
How has the price of PHENTERMINE 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 30 MG CAPSULE has declined 52.3%. It has been tracked across 560 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for PHENTERMINE 30 MG CAPSULE has ranged from a low of $0.1044 (Jul 17, 2024) to a high of $0.2543 (Feb 12, 2014), with a median of $0.1662 per EA.
Are there cheaper alternatives to PHENTERMINE 30 MG CAPSULE?
4 NADAC-published products share the same active ingredient, strength, and dosage form as PHENTERMINE 30 MG CAPSULE, but none are currently priced below it.
Who manufactures PHENTERMINE 30 MG CAPSULE?
PHENTERMINE 30 MG CAPSULE (NDC 51224020270) is labeled by TAGI Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification